Beta Bionics, Inc.
BBNX· Nasdaq
BBNXBeta Bionics, Inc.
Filed Jul 29, 2026 · 10-Q · 29 days after period end · 0001193125-26-323777
| Metric | Q2 2026 | Q2 2025 | Q2 2024 |
|---|---|---|---|
| Revenue | $32.01M | $23.24M | $15.05M |
| Net Income | -$23.40M | -$16.87M | -$14.46M |
| EPS Diluted | -$0.53 | -$0.39 | -$2.37 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Beta Bionics, Inc. · CIK 1674632 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Jul 29, 2026 · 29 d after period end
